Company news
Amarantus Bioscience Holdings, Inc. (OTC:AMBS) news
Amarantus Bioscience Holdings, Inc. news releases on 6ix. Latest, Apr 27, 2022: Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation…
Press releases & updates
Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities
April 26, 2022
Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health
October 7, 2020
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
September 25, 2020
Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million
September 22, 2020
Todos Medical CEO Releases Letter to Shareholders
September 18, 2020
3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma
September 17, 2020
Todos Medical Expands Partnership with Care G.B. Plus for Proprietary TBIA Cancer Tests to Include Europe, Israel and Africa
September 16, 2020
Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July
September 3, 2020
Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment & Supplies With Wisconsin-based Laboratory
August 31, 2020
Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations
August 25, 2020
Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment & Supplies with Texas-based Laboratory
August 24, 2020
Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory
August 21, 2020
Todos Medical Announces Positive Proof-of-Concept Data for Novel 10-Minute Point-of-Care Saliva-based Test Detecting Active SARS-CoV-2 Infection
August 17, 2020
Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid Point-of-Care Antigen Test and Rapid Point-of-Care PCR Test
August 14, 2020
UPDATE: Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
August 10, 2020
Todos Medical Announces July Sales of COVID-19 Tests
August 7, 2020
Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC
August 6, 2020
Todos Medical Appoints Dr. Jorge Leon as Consulting Chief Medical and Scientific Officer of Infectious Disease and Oncology
August 4, 2020
Pathnova Laboratories (PATHNOVA) Enters into Partnership to Commercialize Todos Medicals COVID-19 and Breast Cancer Tests in Singapore
August 3, 2020
Todos Medical Completes Acquisition of Breakthrough Diagnostics, Gains Full Rights to the Alzheimer’s Blood Diagnostic LymPro™ Test from Amarantus
July 28, 2020
Todos Medical Announces SARS-nCoV-19 Testing Kit Contract with NJ-Based Best Supply Clinical Laboratory
July 27, 2020
Todos Medical Expands Management Team and Advisory Board
July 20, 2020
Todos Medical Announces ANVISA Authorization in Brazil for 3D Med qPCR Kits and ANDis Extraction S
July 16, 2020
Todos Medical Enters Into Distribution Partnership With Meridian Health Services Network for COVID-19 Testing Solutions
June 29, 2020
Todos Medical Enters Into Exclusive Distribution Agreement With NLC Pharma for Saliva-based Onsite COVID-19 Diagnostic Test
June 16, 2020
Todos Medical Enters Into Cross-Distribution Agreement With L1 Systems for Ventilators and COVID Testing
May 26, 2020
Todos Medical Announces First Commercial Sale of COVID-19 Antibody Tests
May 18, 2020
Todos Medical Enters Into Direct Exclusive Distribution Agreement With Gnomegen and Announces US FDA Emergency Use Authorization for its COVID-19 qPCR Test Kits
May 11, 2020
Emerald Organic Products Restructures Joint Venture Agreement With Todos Medical by Entering Joint Collaboration Agreement
May 8, 2020
Todos Medical Announces Positive Data for Serology Point-of-Care Fingerprick Antibody Test Kits
April 28, 2020
Todos Medical Announces US FDA Emergency Use Authorization Allowed for Gnomegen COVID-19 PCR Test Kits
April 21, 2020
Todos Medical Appoints Dr. Lauren Chung to its Board of Directors
April 17, 2020
Todos Medical Achieves Medical Importer Status with US FDA
April 15, 2020
Todos Medical Provides Corporate Update
April 9, 2020
Todos Medical Expands on Coronavirus (COVID-19) Distribution Agreement with Shanghai Liangrun Subsidiary Gibraltar
March 30, 2020
Coronavirus (COVID-19)-Focused Joint Venture Formed Between Emerald Organic and Todos Medical to Supply U.S. Market With Rapid Point-of-Care Screening and Confirmatory Testing Kits
March 24, 2020
Todos Medical Signs Novel Coronavirus (COVID-19) Point-of-Care Rapid Antibody Testing Kit Exclusive Distribution Agreement for the United States and Israel with Shanghai Liangrun Subsidiary Gibraltar
March 19, 2020
Todos Medical and 3DMed Enter Into Coronavirus (COVID-19) and Influenza A/B Testing Kit Distribution Agreement in US and Israel
March 17, 2020
UPDATE: Todos Medical Enters Into Coronavirus Nucleic Acid Buccal Testing Kit Distribution Agreement With 3D BioMed
March 17, 2020
Todos Medical Announces Publication Demonstrating Potential of FTIR Platform to Identify Bacterial and Viral Infections
March 2, 2020
Todos Medical Announces Legacy Convertible Note Extension, Lock-Up Agreements, and New Debt Financing
February 25, 2020
Todos Medical Receives Notice of Allowance from European Patent Office Covering Diagnosis of Solid Tumors Using AI to Analyze Blood
February 19, 2020
Todos Medical Releases Letter to Shareholders
February 7, 2020
Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International
February 6, 2020
Amarantus Releases Letter to Shareholders
February 4, 2020
Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
January 30, 2020
Todos Medical Enters into Exclusive Option Agreement to Acquire Provista Diagnostics and Announces Management Changes
January 9, 2020
Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
January 2, 2020
Amarantus to Present at 12th Annual LD Micro Main Event
December 9, 2019
Todos To Present At Upcoming 12th Annual LD Micro Main Event
December 6, 2019